Full-Time

Senior Technical Product Specialist

Medical Device

Posted on 10/7/2025

Mallinckrodt

Mallinckrodt

1,001-5,000 employees

Specialty pharmaceutical developer, manufacturer, distributor

Compensation Overview

$100k - $140k/yr

+ Bonus

Fresno, CA, USA + 10 more

More locations: San Francisco, CA, USA | Los Angeles, CA, USA | Modesto, CA, USA | San Jose, CA, USA | Irvine, CA, USA | Sacramento, CA, USA | San Bernardino, CA, USA | Bakersfield, CA, USA | San Diego, CA, USA | Riverside-San Bernardino-Ontario, CA, CA, USA

Hybrid

This position is eligible for remote work with domestic and international travel requirements of at least 40%.

Category
Biology & Biotech (4)
, , ,
Required Skills
Assembly
Requirements
  • Bilingual proficiency in English and Japanese
  • Associate’s or Bachelor’s degree in Biomedical Engineering or a related field, or equivalent military experience
  • 4+ years of experience in medical device cGMP service, manufacturing, or a comparable combination of service and support experience
  • Proven ability to work independently and lead staff toward meeting deadlines
  • Strong problem-solving abilities with a focus on process improvement
  • Must work Pacific Standard Time (PST) zone
Responsibilities
  • Serving as a subject matter expert, able to perform Service Support and assist Product Support functions, including diagnosis and troubleshooting of complaint device faults and failures, assisting with device application and triaging repairs with international business partners
  • Including but not limited to, use-case troubleshooting, assembly / disassembly, service log review and interpretation, familiarity with component test methods for final Field Replaceable Unit FRU assemblies per manufacturing documentation
  • Diving deep into device assembly, disassembly, inner workings and end user applications, each day brings new technical challenges that will keep your problem-solving skills sharp and your work engaging
Desired Qualifications
  • Product management experience, especially with mechanical ventilation or other respiratory care products
  • Background in customer support or service, including phone-based troubleshooting
  • Familiarity with Field Replaceable Unit (FRU) service model processes
  • Proficiency with SAP or a similar enterprise database system
  • Advanced skills in Microsoft Office applications (Excel, Word, PowerPoint, Visio, etc.)

Mallinckrodt is a global specialty pharmaceutical company that develops, manufactures, and distributes drugs and therapies for complex and rare conditions, serving healthcare providers, hospitals, and patients mainly in the United States and Europe. Its products target areas such as autoimmune diseases, rare diseases, and critical care, and the business rests on research and development, manufacturing, and sales. The company differentiates itself through a patient-centric approach, a commitment to integrity, ongoing innovation, and collaboration, grounded in more than 150 years of experience and a focus on ESG initiatives. Its goal is to improve the health and well-being of patients worldwide by delivering specialty medicines and advancing sustainable practices.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Hazelwood, Missouri

Founded

1867

Simplify Jobs

Simplify's Take

What believers are saying

  • Merger with Endo completed, forming NYSE-listed therapeutics leader by Q4 2025.
  • Reduced debt 47% to $865.6M and grew Acthar Gel sales 14.2% in 2024.
  • Sold Therakos for $925M, optimizing portfolio for specialty pharmaceuticals.

What critics are saying

  • Endo merger integration disrupts operations, overloading with $6.7B debt.
  • Therakos sale drops immunotherapy revenue, losing edge to Amgen immediately.
  • Acthar Gel's $300K pricing triggers DOJ probe and $500M fines within 18 months.

What makes Mallinckrodt unique

  • Mallinckrodt specializes in Acthar Gel for autoimmune diseases over 150 years.
  • Focuses on rare diseases and critical care therapies for underserved patients.
  • Launched Acthar Gel self-injectable to improve patient adherence and convenience.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Relocation Assistance

Company News

PR Newswire
Nov 10th, 2025
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables

Launches as Top 15 U.S. Generic Drug Manufacturer, Largest U.S. Producer of Active Pharmaceutical Ingredients and Premier U.S. Producer of Sterile Injectables...

Contract Pharma
Aug 6th, 2025
Mallinckrodt Names Christiana Stamoulis President and CFO

Mallinckrodt plc appointed Christiana Stamoulis as President and Chief Financial Officer, effective September 22, 2025.

Stock Titan
Aug 1st, 2025
Mallinckrodt-Endo Merger Creates Therapeutics Leader

Mallinckrodt and Endo have completed a merger to form a global therapeutics leader. The companies will combine their generics businesses and Endo's sterile injectables business, which will be spun off as an independent company by Q4 2025. The newly branded company will be listed on the New York Stock Exchange following the spin-off.

The Business Journals
Jul 25th, 2025
Mallinckrodt Reaches $7B Merger Milestone

Mallinckrodt has reached a milestone in a $7 billion merger deal.

Sharecast
Mar 13th, 2025
Mallinckrodt and Endo to merge in $6.7bn deal

Pharmaceutical firm Mallinckrodt said on Thursday that it has agreed to merge with Endo in a $6.7bn deal.

INACTIVE